Evidence map›Paper›PMID 42911528›Full record

ReviewLa Radiologia medica2026

The evolution of image-guided ablations for thyroid disorders: a historical review.

Giovanni Mauri, Eleonora Rossi, Enrico Papini, Luigi Solbiati, Stefano Spiezia, Jung Hwan Baek, Luca Maria Sconfienza

Abstract readReview
PubMed Publisher
In one paragraph

Review in La Radiologia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Giovanni MauriUnit of Diagnostic and Interventional Radiology, IRCCS Ospedale Galeazzi-Sant'Ambrogio, Milan, Italy.
Eleonora RossiUniversità Degli Studi Di Milano, Via Festa del Perdono 7, 20122, Milan, Italy. eleonora.rossi4@unimi.it.ORCID http://orcid.org/0009-0008-2005-4432
Enrico PapiniDepartment of Endocrine and Metabolic Diseases, Regina Apostolorum Hospital-Lifenet Health Group, Albano, Rome, Italy.
Luigi SolbiatiDepartment of Biomedical Science, Humanitas University and Humanitas Clinical and Research Hospital IRCCS, Rozzano, Italy.
Stefano SpieziaDepartment of Surgery, Endocrine and Ultrasound-Guided Surgery Unit, Ospedale del Mare, ASL Napoli 1, Naples, Italy.
Jung Hwan BaekDepartment of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Luca Maria SconfienzaUnit of Diagnostic and Interventional Radiology, IRCCS Ospedale Galeazzi-Sant'Ambrogio, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past four decades, the management of thyroid nodules and selected thyroid malignancies has progressively shifted from surgery-centered approaches toward image-guided minimally invasive treatments (MITT). What began in 1985 with ultrasound-guided percutaneous ethanol injection evolved into a range of energy-based techniques, including laser ablation (LA), radiofrequency ablation (RFA), microwave ablation (MWA), and high-intensity focused ultrasound (HIFU).This historical review aimed to reconstruct the major milestones in the development of image-guided thyroid ablation. A systematic PubMed literature search and predefined selection criteria were used to identify seminal studies, first clinical applications, major technological innovations, comparative studies, guideline-defining publications, and landmark long-term follow-up studies. Overall, 43 milestone papers were included for qualitative historical analysis. The evolution of thyroid ablation can be divided into five phases: conceptual origins (1985-1999), birth of the thermal procedures' era (2000-2006), methodological standardization (2007-2012), oncologic consolidation and comparative evidence (2013-2018), and final codification by means of international guideline endorsement and long-term validation (2019-2025). Recent 10-year follow-up studies have confirmed the durable efficacy of MITT for benign nodule management and their sustained oncologic control in low-risk papillary thyroid microcarcinoma. Image-guided thyroid ablation has transitioned from experimental innovation to an evidence-based, guideline-supported therapeutic domain, representing a paradigm shift toward precision medicine, organ preservation, and minimally invasive endocrine oncology.

Indexed as

HIFULaser ablationMicrowave ablationRadiofrequency ablationThyroid ablation

Identifiers

PMID42911528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.